Galina Kompanets

Dr. Galina Kompanets

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NKNatalya Krylova
Natalya Krylova
SESvetlana Ermakova
Svetlana Ermakova
VLVyacheslav F. Lavrov
Vyacheslav F. Lavrov
ILIrina Leneva
Irina Leneva
GKGalina Kompanets
Galina Kompanets
TZTatyana S. Zaporozhets
Tatyana S. Zaporozhets
The enzymatic depolymerization of fucoidans from brown algae allowed the production of their standardized derivatives with different biological activities. This work aimed to compare the antiviral activities of native (FeF) and modified with enzyme (FeHMP) fucoidans from F. evanescens. The cytotoxicity and antiviral activities of the FeF and FeHMP against herpes viruses (HSV-1, HSV-2), enterovirus (ECHO-1), and human immunodeficiency virus (HIV-1) in Vero and human MT-4 cell lines were examined by methylthiazolyltetrazolium bromide (MTT) and cytopathic effect (CPE) reduction assays, respectively. The efficacy of fucoidans in vivo was evaluated in the outbred mice model of vaginitis caused by HSV-2. We have shown that both FeF and FeHMP significantly inhibited virus-induced CPE in vitro and were more effective against HSV. FeF exhibited antiviral activity against HSV-2 with a selective index (SI) > 40, and FeHMP with SI ˃ 20, when they were added before virus infection or at the early stages of the HSV-2 lifecycle. Furthermore, in vivo studies showed that after intraperitoneal administration (10 mg/kg), both FeF and FeHMP protected mice from lethal intravaginal HSV-2 infection to approximately the same degree (44–56%). Thus, FeF and FeHMP have comparable potency against several DNA and RNA viruses, allowing us to consider the studied fucoidans as promising broad-spectrum antivirals.

1 September 2000 in Virus Research
Verified
Journal Article
Closed access
LYLyudmila N. Yashina
Lyudmila N. Yashina
NPNikolai A. Patrushev
Nikolai A. Patrushev
LILeonid I. Ivanov
Leonid I. Ivanov
RSRaisa A. Slonova
Raisa A. Slonova
VMVasiliy P. Mishin
Vasiliy P. Mishin
SNSergey Victorovich Netesov
Sergey Victorovich Netesov

15 October 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NKNatalya Krylova
Natalya Krylova
ASArtem Silchenko
Artem Silchenko
APAnastasiya Pott
Anastasiya Pott
SESvetlana Ermakova
Svetlana Ermakova
OIOlga Iunikhina
Olga Iunikhina
Mikhail Yurievich ShchelkanovMikhail Yurievich Shchelkanov
Mikhail Yurievich Shchelkanov
The Hantaan orthohantavirus (genovariant Amur–AMRV) is a rodent-borne zoonotic virus; it is the causative agent of haemorrhagic fever with renal syndrome in humans. The currently limited therapeutic options require the development of effective anti-orthohantavirus drugs. The ability of native fucoidan from Fucus evanescens (FeF) and its enzymatically prepared high-molecular-weight (FeHMP) and low-molecular-weight (FeLMP) fractions to inhibit different stages of AMRV infection in Vero cells was studied. The structures of derivatives obtained were determined using nuclear magnetic resonance (NMR) spectroscopy. We found that fucoidan and its derivatives exhibited significant antiviral activity by affecting the early stages of the AMRV lifecycle, notably virus attachment and penetration. The FeHMP and FeLMP fractions showed the highest anti-adsorption activity by inhibiting AMRV focus formation, with a selective index (SI) > 110; FeF had an SI of ~70. The FeLMP fraction showed a greater virucidal effect compared with FeF and the FeHMP fraction. It was shown by molecular docking that 2O-sulphated fucotetrasaccharide, a main component of the FeLMP fraction, is able to bind with the AMRV envelope glycoproteins Gn/Gc and with integrin β3 to prevent virus–cell interactions. The relatively small size of these sites of interactions explains the higher anti-AMRV activity of the FeLMP fraction.

4 March 2016 in Food and Environmental Virology
Verified
Journal Article
Closed access
PDF file
SPStanislav N. Pavliga
Stanislav N. Pavliga
GKGalina Kompanets
Galina Kompanets
Vasiliy Yu. TsygankovVasiliy Yu. Tsygankov
Vasiliy Yu. Tsygankov

11 March 2023 in Problems of Virology
Verified
Journal Article
Open access
PDF file
LYLiudmila N Yashina
Liudmila N Yashina
LIL. I. Ivanov
L. I. Ivanov
GKGalina Kompanets
Galina Kompanets
NZN. I. Zdanovskaya
N. I. Zdanovskaya
MKM. Yu. Kartashov
M. Yu. Kartashov
Introduction. Insectivores are newly recognized hantaviral reservoir worldwide. Four distinct shrew-borne hantaviruses (family Hantaviridae) have been identified in two regions located in southern and northern part of the Russian Far East, two genetic variants of Seewis virus (SWSV), Lena River virus (LENV), Kenkeme virus (KKMV) and Yakeshi virus (YKSV). Here, we describe geographic distribution of shrew-borne hantaviruses in southern part of the Russian Far East: Jewish Autonomous region, Khabarovsk Krai, Primorsky Krai and Sakhalin region. Materials and methods. Lung samples from shrews of genus Sorex, captured in the four regions of Far Eastern Russia, were examined for hantavirus RNA using reverse transcription polymerase chain reaction (RT-PCR). Phylogenetic analysis of the partial nucleotide sequences of viral genome was conducted using MEGA X software. Results. New genetic variant of YKSV was identified in new reservoir host, long-clawed shrew (S. ungiuculatus) from Sakhalin Island. Genetic variant of SWSV, ARTV-Sc, has been found to circulate among S. caecutiens on the seacoast of Khabarovsk and Primorsky Krai. KKMV virus and second genetic variant of SWSV, ARTV-St, were found in S. roboratus and S. tundrensis, respectively from Jewish Autonomous region. Conclusion. Sorex-borne hantaviruses were found in all studied regions of Far Eastern Russia. Our results demonstrated co-evolution of SWSV, KKMV, and YKSV viruses throughout the geographic distribution of its hosts.

27 June 2019 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
SPSergey G. Polonik
Sergey G. Polonik
NKNatalya Krylova
Natalya Krylova
GKGalina Kompanets
Galina Kompanets
OIOlga Iunikhina
Olga Iunikhina
YSYuri Sabutski
Yuri Sabutski
Four 1,4-naphthoquinone dithioglucoside derivatives based on natural polyhydroxy-1,4-naphthoquinones were synthesized. These thioglucosides were screened for their antiradical and antiviral activity in vitro. Antiradical activity of tested compounds was determined by the 2,2-diphenyl-1-picrylhydrazyl radical scavenging assay. The anti-herpes simplex virus type 1 (anti-HSV-1) activity of thioglucosides was analyzed by the cytopathic effect inhibition assay and mode of antiviral action was determined by the addition of the tested compounds to uninfected cells, to the virus prior to infection, or to herpes-infected cells. Most effective inhibition of HSV-1 replication was observed at pretreatment of virus by the compounds (direct virucidal effect). The dithioglucoside conjugate with the single β-OH group and lipophilic ethyl substituent in naphthoquinone core showed the greatest antiviral activity.